FXR
Farnesoid X Receptor (FXR) is a nuclear receptor that plays a key role in the regulation of bile acid homeostasis, lipid metabolism, and glucose regulation. FXR is a potential therapeutic target for treating liver diseases, metabolic disorders, and cardiovascular diseases. FXR inhibitors can modulate these pathways, offering insights into disease mechanisms and therapeutic strategies. At CymitQuimica, we provide a range of FXR inhibitors to support your research in hepatology, metabolism, and drug development.
Found 58 products of "FXR"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Chenodeoxycholic acid
CAS:<p>Chenodeoxycholic acid (CDCA) is a bile acid that inhibits 11β-HSD2 with an IC50 value of 22 mM. High-Quality, Low-Cost!</p>Formula:C24H40O4Purity:99.70% - 99.93%Color and Shape:White - Almost White Solid PowderMolecular weight:392.57Ursodeoxycholic acid
CAS:<p>Ursodeoxycholic acid (UDCA) is a potent inhibitor of liver-specific fatty acid transporter 5 (FATP5),inhibits cholesterol absorption. High-Quality, Low-Cost!</p>Formula:C24H40O4Purity:99.74% - ≥95%Color and Shape:White - Almost White Solid PowderMolecular weight:392.57LY2562175
CAS:<p>LY2562175 is an effective and selective FXR agonist (EC50: 193 nM).</p>Formula:C28H27Cl2N3O4Purity:99.16% - 99.78%Color and Shape:SolidMolecular weight:540.44Alismanol M
CAS:<p>Alismanol M: FXR agonist, EC50 of 50.25 μM, from Alisma orientale, for cholestasis & NASH research.</p>Formula:C30H48O6Color and Shape:SolidMolecular weight:504.7Nuclear Receptor Compound Library
<p>A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;</p>Color and Shape:Odour SolidFexarene
CAS:<p>Fexarene is a non-steroidal FXR agonist.</p>Formula:C32H33NO3Purity:98%Color and Shape:SolidMolecular weight:479.62Tauro-β-muricholic acid sodium
CAS:<p>Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).</p>Formula:C26H44NNaO7SPurity:98%Color and Shape:SolidMolecular weight:537.69ZLY28
<p>ZLY28 is a novel, first-in-class compound with specific intestinal restriction and oral activity, serving as a dual modulator of FXR and FABP1.</p>Formula:C29H23Cl2NO4Purity:98%Color and Shape:SolidMolecular weight:520.4FXR agonist 11
CAS:<p>FXR agonist11 (Compound 14) is an FXR activator with an EC50 of 1.2 μM and a maximal effect of 73.7%. It significantly increases GSH levels in the liver and is used to study drug-induced liver injury.</p>Formula:C18H16N2O5Color and Shape:SolidMolecular weight:340.33LZ-007
CAS:<p>LZ-007 is an agonist of the Farnesoid X receptor (FXR), with an EC50 of 51 nM as determined by TR-FRET assay, and an EC50 of 76 nM in HepG2 cells. It exhibits favorable pharmacokinetic properties in SD rats and can improve metabolic dysfunction-associated steatohepatitis induced by high-fat diets and CCl4 in mice.</p>Formula:C27H29F3N2O5Color and Shape:SolidMolecular weight:518.53FXR antagonist 2
CAS:<p>Compound A-26, a diarylamide FXR blocker, may aid hyperlipidemia and diabetes type 2 research.</p>Formula:C22H26Cl2N2O2Color and Shape:SolidMolecular weight:421.36FXR/TGR5 agonist 1
CAS:<p>FXR/TGR5 agonist 1 acts as an agonist on both FXR and TGR5 receptors and is utilized for treating fatty liver disease.</p>Formula:C31H32ClN3O3Color and Shape:SolidMolecular weight:530.07LH10
<p>LH10 is an FXR agonist based on fexaramine, with an EC50 of 0.14 μM. It offers hepatoprotective effects, mitigating conditions such as cholestasis induced by alpha naphthylisothiocyanate (ANIT), acute liver injury caused by APAP, and non-alcoholic steatohepatitis (NASH).</p>Formula:C34H33N3O2Color and Shape:SolidMolecular weight:515.64FXR agonist 10
<p>FXR agonist10 (Compound 27) acts as an agonist for FXR with an EC50 of 14.26 μM. It increases the expression of SHP and BSEP proteins while decreasing the expression of NTCP and CYP7A1 proteins. Additionally, FXR agonist10 has been shown to ameliorate ANIT-induced cholestasis in mouse models.</p>Formula:C15H22O4Color and Shape:SolidMolecular weight:266.33FXR agonist 5
CAS:<p>FXR agonist 5 is an FXR agonist used in the study of liver diseases or diseases mediated by metabolic inflammation.</p>Formula:C40H53N5O5Purity:99.74%Color and Shape:SolidMolecular weight:683.88NR1H4 Protein, Mouse, Recombinant (His)
<p>NR1H4 Protein, Mouse, Recombinant (His) is expressed in E. coli expression system with His tag. The predicted molecular weight is 27.80 kDa.</p>Color and Shape:Lyophilized PowderMolecular weight:27.80 kDa (predicted)NR1H4 Protein, Human, Recombinant (His)
<p>NR1H4 Protein, Human, Recombinant (His) is expressed in E.</p>Color and Shape:Lyophilized PowderMolecular weight:27.83 kDa (predicted)NDB
CAS:<p>NDB is a hFXRα antagonist that inhibits GW4064-stimulated FXR/RXR interactions in primary mouse hepatocytes.NDB is used in the study of diabetes.</p>Formula:C26H28Cl2N2O2Purity:98.94%Color and Shape:SolidMolecular weight:471.42FXR agonist 3
<p>FXR agonist 3 is an anti NASH compound with anti-fibrotic and active properties that inhibits the expression of COL1A1, TGF-β1, α-SMA and TIMP1.</p>Formula:C28H28BrNO4Purity:95.04%Color and Shape:SolidMolecular weight:521.12DY268
CAS:<p>DY268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist.</p>Formula:C30H32N4O5SPurity:99.43% - 99.75%Color and Shape:SolidMolecular weight:560.66Tauro-Obeticholic acid
CAS:<p>Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).</p>Formula:C28H49NO6SPurity:99.74% - 99.82%Color and Shape:SolidMolecular weight:527.76Ursodeoxycholic acid sodium
CAS:<p>Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities.</p>Formula:C24H40NaO4Purity:99.66% - 99.96%Color and Shape:SolidMolecular weight:415.56GW 4064
CAS:<p>GW 4064 is an effective farnesoid X receptor (FXR) agonist (EC50 =65 nM).</p>Formula:C28H22Cl3NO4Purity:98% - 99.94%Color and Shape:SolidMolecular weight:542.84Obeticholic Acid
CAS:<p>Obeticholic Acid (6-ECDCA, INT-747) is a high-affinity, semisynthetic, bile acid-derived FXR agonist.Cost-effective and quality-assured.</p>Formula:C26H44O4Purity:99.88% - 99.97%Color and Shape:SolidMolecular weight:420.63Sevelamer hydrochloride
CAS:<p>Sevelamer hydrochloride (Sevelamer HCl) is a phosphate binding drug used to treat hyperphosphatemia via binding to dietary phosphate and prevents its absorption</p>Formula:(C3H7N·C3H5ClO·HCl)xPurity:98%Color and Shape:SolidMolecular weight:186.08Tropifexor
CAS:<p>Tropifexor (LJN452) is a novel and highly potent agonist of FXR with an EC50 of 0.2 nM.</p>Formula:C29H25F4N3O5SPurity:99.3% - 99.85%Color and Shape:SolidMolecular weight:603.58Turofexorate Isopropyl
CAS:<p>Turofexorate Isopropyl (XL335) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM</p>Formula:C25H24F2N2O3Purity:98.55% - 99.73%Color and Shape:SolidMolecular weight:438.47BAR 501 impurity
CAS:<p>BAR 501 impurity 在 BAR501 制剂中发现的一种杂质，可作为 G 蛋白偶联胆汁酸激活受体 (GP-BAR1) 的激动剂。 BAR501 杂质 (10 µM) 在 GP-BAR1 报告基因检测中诱导荧光素酶活性增加 150%。</p>Formula:C26H46O3Purity:98.78%Color and Shape:SolidMolecular weight:406.64BAR502
CAS:<p>BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM).</p>Formula:C25H44O3Purity:99.95%Color and Shape:SolidMolecular weight:392.62Guggulsterone
CAS:<p>Guggulsterone (Guggulsterone E&Z) E&Z is a 3-hydroxy steroid. It has a role as an androgen.</p>Formula:C21H28O2Purity:99.4% - 99.8%Color and Shape:Light Yellow PowderMolecular weight:312.45Nidufexor
CAS:<p>Nidufexor is an agonist for the farnesoid X receptor (FXR).</p>Formula:C27H22ClN3O4Purity:98.67%Color and Shape:SolidMolecular weight:487.93T0901317
CAS:<p>T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).</p>Formula:C17H12F9NO3SPurity:98% - 99.64%Color and Shape:SolidMolecular weight:481.33Vidofludimus
CAS:<p>Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).</p>Formula:C20H18FNO4Purity:98.33% - 99.58%Color and Shape:SolidMolecular weight:355.36Glyco-Obeticholic acid
CAS:<p>Glyco-Obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an agonist of the farnesoid X receptor (FXR).</p>Formula:C28H47NO5Purity:99.77% - 99.95%Color and Shape:SolidMolecular weight:477.68Fexaramine
CAS:<p>Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity compared to natural compounds.</p>Formula:C32H36N2O3Purity:98.87% - 99.61%Color and Shape:SolidMolecular weight:496.64Forskolin
CAS:<p>Forskolin (Coleonol) is a natural product, an adenylate cyclase activator (EC50=0.5 μM).</p>Formula:C22H34O7Purity:98.83% - 99.96%Color and Shape:Less Crystalline Solid Colorless Crystalline SolidMolecular weight:410.5Cilofexor
CAS:<p>Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist.</p>Formula:C28H22Cl3N3O5Purity:99.86% - ≥95%Color and Shape:SolidMolecular weight:586.85Vonafexor
CAS:<p>Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects</p>Formula:C19H15Cl3N2O5SPurity:98.74%Color and Shape:SolidMolecular weight:489.76Teduglutide
CAS:<p>Teduglutide (ALX-0600) is a glucagon-like peptide-2 analog that increases intestinal absorption and can be used in research on short bowel syndrome (SBS).</p>Formula:C164H252N44O55SPurity:98.08%Color and Shape:SolidMolecular weight:3752.08EDP-305
CAS:<p>EDP-305, an oral FXR agonist, has EC50s of 34 nM/8 nM in CHO/HEK cells, aids in PBC and NASH research with antifibrotic properties.</p>Formula:C36H58N2O5SColor and Shape:SolidMolecular weight:630.92ST-1892
CAS:<p>ST-1892 is a soluble partial FXR agonist.</p>Formula:C16H12N2O3Purity:98%Color and Shape:SolidMolecular weight:280.28PX20606
CAS:<p>PX20606 is an orally active farnesoid X receptor (FXR) agonist, demonstrating EC50 values of 220 nM (mFXR) and 50 nM (hFXR) in Gal4-FXR assays. It induces the expression of the tumor suppressor gene NDRG2 and inhibits tumor growth and metastasis in a mouse HCC model. Additionally, PX20606 exhibits hepatoprotective properties.</p>Formula:C29H22Cl3NO4Color and Shape:SolidMolecular weight:554.85FXR agonist 4
<p>FXR agonist 4: EC50 of 1.05μM, treats hyperlipidemia, steatosis, insulin resistance, inflammation in DIO mice, for NAFLD research.</p>Formula:C21H28ClN3OColor and Shape:SolidMolecular weight:373.92LY367385
CAS:<p>LY367385 is a highly effective and selective mGluR1a antagonist.</p>Formula:C10H11NO4Purity:98%Color and Shape:SolidMolecular weight:209.2Fexarine
CAS:<p>Fexarine is a potent, selective agonist of farnesoid X receptor.</p>Formula:C31H31NO5Color and Shape:SolidMolecular weight:497.58GSK-8062
CAS:<p>GSK-8062 is an agonist of farnesoid X receptor (FXR).</p>Formula:C30H23Cl2NO4Purity:98%Color and Shape:SolidMolecular weight:532.41BMS-986318
CAS:<p>BMS-986318: potent FXR agonist, EC50=53/350 nM, good ADME, effective in liver disease models, for nonalcoholic steatohepatitis research.</p>Formula:C30H23Cl2F3N4O3Color and Shape:SolidMolecular weight:615.43FXR antagonist 1
CAS:<p>"Oral FXR antagonist 1 selectively blocks intestinal FXR, with IC50 of 2.1 μM, aiding in NASH research by improving liver health."</p>Formula:C36H59NO5Color and Shape:SolidMolecular weight:585.86GSK2324
CAS:<p>GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.</p>Formula:C29H22Cl2N2O4Purity:98.09% - 99.02%Color and Shape:SolidMolecular weight:533.4FXR agonist 9
CAS:<p>FXR agonist9 (compound 26) is a selective, orally active partial agonist of FXR with an EC50 of 0.09 µM (maximum efficacy of 75.13%). It ameliorates the pathological features of fatty liver disease in mice induced by HFD and CCl4-related metabolic dysfunction.</p>Formula:C28H30N2O5Color and Shape:SolidMolecular weight:474.55Omesdafexor
CAS:<p>Omesdafexor is an FXR agonist that can be used to study diseases caused by liver disease or metabolic inflammation.</p>Formula:C34H43N3O3Color and Shape:SolidMolecular weight:541.72NR1H4 activator 1
CAS:<p>NR1H4 activator 1 is a potent and selective agonist of Famesoid X Receptor (FXR).</p>Formula:C34H53NO7SPurity:98%Color and Shape:SolidMolecular weight:619.85FXR agonist 12
CAS:<p>FXR agonist12 (Compound C7) is an orally active FXR agonist. It downregulates bile acid synthesis-related genes and upregulates bile acid transport-related genes in HepG2 cells. FXR agonist12 alleviates ANIT-induced cholestasis and reduces liver damage and fibrosis in a mouse model of NASH.</p>Formula:C26H44O3Color and Shape:SolidMolecular weight:404.626BMS-986339
CAS:<p>BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.</p>Formula:C35H41F4N3O4Color and Shape:SolidMolecular weight:643.71Danifexor
CAS:<p>Danifexor is an agonist of the farnesoid X receptor (Farnesoid X receptor).</p>Formula:C29H20Cl2N2O5Color and Shape:SolidMolecular weight:547.386FXR/CES2 modulator 1
CAS:<p>Compound LE-77, known as FXR/CES2 modulator 1, functions as a dual regulator that activates FXR and inhibits CES2. It effectively mitigates the intestinal toxicity of irinotecan.</p>Formula:C27H21Cl2NO5Color and Shape:SolidMolecular weight:510.36Lecufexor
CAS:<p>Lecufexor is an agonist of the farnesoid X receptor (FXR).</p>Formula:C32H21Cl3N2O5Color and Shape:SolidMolecular weight:619.88BAR-2227
CAS:<p>BAR-2227 (compound 3a) functions as an FXR agonist and a LIFR inhibitor. It is utilized in the study of liver fibrosis and inflammation.</p>Formula:C24H17Cl2NO4Color and Shape:SolidMolecular weight:454.30
